Viewing Study NCT04188405

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:27 AM
Ignite Modification Date: 2026-03-03 @ 8:11 AM
Study NCT ID: NCT04188405
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-20
First Post: 2019-11-25
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Decitabine, Venetoclax, and Ponatinib for the Treatment of Philadelphia Chromosome-Positive Acute Myeloid Leukemia or Myeloid Blast Phase or Accelerated Phase Chronic Myelogenous Leukemia
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive View
None Acute Myeloid Leukemia View
None Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive View
None Recurrent Acute Myeloid Leukemia View
None Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive View
None Refractory Acute Myeloid Leukemia View
None Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive View
Keywords: